The Federal Circuit has denied the petition for rehearing en banc in Ariosa Diagnostics, Inc. v. Sequenom, Inc., despite the filing of twelve amicus briefs in support of the petition, including briefs filed by Biotechnology Industry Organization and Pharmaceutical Research and Manufacturers of America, numerous innovator companies in the diagnostic space, and law professors. The en banc order was accompanied by concurring opinions authored by Judge Lourie (joined by Judge Moore) and Judge Dyk, and a dissenting opinion authored by Judge Newman.
The panel decision is discussed in this article.
Disclaimer
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.
Author(s)
Related Insights
June 12, 2026
Manufacturing Industry Advisor
International Compliance and Risk-Mitigation Heat Map (2026 Update)
These interactive international compliance and risk-mitigation heat maps present quick visual indications of relative bribery, sanctions, and human rights compliance risks in every country around the globe.
June 12, 2026
Foley Viewpoints
America at 250: Why the Next Wave of Innovation Will Be Built Across Borders
As the United States approaches its 250th anniversary, it is worth reflecting on one of the country’s defining competitive advantages: its longstanding commitment to cross-border collaboration. The next wave of innovation is increasingly being built across borders, particularly between the United States and Latin America. Venture capital investors, strategic acquirers, and technology companies no longer view Latin America solely as an emerging market, but instead as a growing source of sophisticated founders, scalable technology companies, engineering talent, and sector-specific innovation.
June 12, 2026
Labor & Employment Law Perspectives
3 New Pay Transparency State Laws Raise Compliance Risks
Three recent developments — Delaware's newly enacted wage transparency law, Maine's recently signed pay transparency statute, and New Jersey's proposed implementing regulations related to its wage transparency law — illustrate the continued momentum in this area and underscore the need for employers to remain apprised of changes and updates to the law.